MedTrace Logo

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

NCT01359930 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-01-12

No results posted yet for this study

Summary

The study is to primarily measure safety and interactions between oral doses of Naltrexone/Bupropion and i.v. Methamphetamine.

Conditions

  • Methamphetamine Dependence

Interventions

OTHER

placebo

matching placebo

DRUG

Naltrexone and Bupropion SR

25mg bid/day (NX) 200mg bid/day (BUP)

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01359930 on ClinicalTrials.gov